Literature DB >> 28388439

Celastrol-Induced Nur77 Interaction with TRAF2 Alleviates Inflammation by Promoting Mitochondrial Ubiquitination and Autophagy.

Mengjie Hu1, Qiang Luo2, Gulimiran Alitongbieke1, Shuyi Chong1, Chenting Xu1, Lei Xie1, Xiaohui Chen1, Duo Zhang1, Yuqi Zhou1, Zhaokai Wang2, Xiaohong Ye1, Lijun Cai1, Fang Zhang2, Huibin Chen3, Fuquan Jiang1, Hui Fang2, Shanjun Yang2, Jie Liu1, Maria T Diaz-Meco4, Ying Su5, Hu Zhou1, Jorge Moscat4, Xiangzhi Lin2, Xiao-Kun Zhang6.   

Abstract

Mitochondria play an integral role in cell death, autophagy, immunity, and inflammation. We previously showed that Nur77, an orphan nuclear receptor, induces apoptosis by targeting mitochondria. Here, we report that celastrol, a potent anti-inflammatory pentacyclic triterpene, binds Nur77 to inhibit inflammation and induce autophagy in a Nur77-dependent manner. Celastrol promotes Nur77 translocation from the nucleus to mitochondria, where it interacts with tumor necrosis factor receptor-associated factor 2 (TRAF2), a scaffold protein and E3 ubiquitin ligase important for inflammatory signaling. The interaction is mediated by an LxxLL motif in TRAF2 and results not only in the inhibition of TRAF2 ubiquitination but also in Lys63-linked Nur77 ubiquitination. Under inflammatory conditions, ubiquitinated Nur77 resides at mitochondria, rendering them sensitive to autophagy, an event involving Nur77 interaction with p62/SQSTM1. Together, our results identify Nur77 as a critical intracellular target for celastrol and unravel a mechanism of Nur77-dependent clearance of inflamed mitochondria to alleviate inflammation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Celastrol; Nur77; TR3; TRAF2; autophagy; inflammation; mitochondria; mitophagy; nuclear receptor; p62/SQSTM1

Mesh:

Substances:

Year:  2017        PMID: 28388439      PMCID: PMC5761061          DOI: 10.1016/j.molcel.2017.03.008

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  72 in total

Review 1.  Coactivator and corepressor complexes in nuclear receptor function.

Authors:  L Xu; C K Glass; M G Rosenfeld
Journal:  Curr Opin Genet Dev       Date:  1999-04       Impact factor: 5.578

2.  Nur77: orphaned at birth but adopted by the nuclear factor kappaB signaling pathway.

Authors:  Paul C Evans
Journal:  Circ Res       Date:  2009-03-27       Impact factor: 17.367

3.  Molecular understanding and modern application of traditional medicines: triumphs and trials.

Authors:  Timothy W Corson; Craig M Crews
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

4.  Treatment of obesity with celastrol.

Authors:  Junli Liu; Jaemin Lee; Mario Andres Salazar Hernandez; Ralph Mazitschek; Umut Ozcan
Journal:  Cell       Date:  2015-05-21       Impact factor: 41.582

Review 5.  Targeting Nur77 translocation.

Authors:  Xiao-kun Zhang
Journal:  Expert Opin Ther Targets       Date:  2007-01       Impact factor: 6.902

Review 6.  Tumor necrosis factor receptor-associated factors (TRAFs).

Authors:  J R Bradley; J S Pober
Journal:  Oncogene       Date:  2001-10-01       Impact factor: 9.867

7.  PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.

Authors:  Sven Geisler; Kira M Holmström; Diana Skujat; Fabienne C Fiesel; Oliver C Rothfuss; Philipp J Kahle; Wolfdieter Springer
Journal:  Nat Cell Biol       Date:  2010-01-24       Impact factor: 28.824

8.  Negative cross-talk between the human orphan nuclear receptor Nur77/NAK-1/TR3 and nuclear factor-kappaB.

Authors:  Hanna Harant; Ivan J D Lindley
Journal:  Nucleic Acids Res       Date:  2004-10-05       Impact factor: 16.971

9.  Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3.

Authors:  Bingzhen Lin; Siva Kumar Kolluri; Feng Lin; Wen Liu; Young-Hoon Han; Xihua Cao; Marcia I Dawson; John C Reed; Xiao-kun Zhang
Journal:  Cell       Date:  2004-02-20       Impact factor: 41.582

10.  MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades.

Authors:  Siqi Liu; Jueqi Chen; Xin Cai; Jiaxi Wu; Xiang Chen; You-Tong Wu; Lijun Sun; Zhijian J Chen
Journal:  Elife       Date:  2013-08-14       Impact factor: 8.140

View more
  71 in total

1.  Celastrol ameliorates acute liver injury through modulation of PPARα.

Authors:  Qi Zhao; Ping Tang; Ting Zhang; Jian-Feng Huang; Xue-Rong Xiao; Wei-Feng Zhu; Frank J Gonzalez; Fei Li
Journal:  Biochem Pharmacol       Date:  2020-05-26       Impact factor: 5.858

2.  Comparative transcriptomics and network pharmacology analysis to identify the potential mechanism of celastrol against osteoarthritis.

Authors:  Siming Dai; Hui Wang; Meng Wang; Yue Zhang; Zhiyi Zhang; Zhiguo Lin
Journal:  Clin Rheumatol       Date:  2021-04-19       Impact factor: 2.980

3.  Nur77 promotes cerebral ischemia-reperfusion injury via activating INF2-mediated mitochondrial fragmentation.

Authors:  Hao Zhao; Wenlong Pan; Lihua Chen; Yongchun Luo; Ruxiang Xu
Journal:  J Mol Histol       Date:  2018-10-08       Impact factor: 2.611

4.  BI1071, a Novel Nur77 Modulator, Induces Apoptosis of Cancer Cells by Activating the Nur77-Bcl-2 Apoptotic Pathway.

Authors:  Xihua Cao; Liqun Chen; Xiaohui Chen; Xuhuang Tu; Gulimiran Alitongbieke; Zebin Xia; Xiaotong Li; Ziwen Chen; Meimei Yin; Dan Xu; Shangjie Guo; Zongxi Li; Xindao Zhang; Dingyu Xu; Meichun Gao; Jie Liu; Zhiping Zeng; Hu Zhou; Ying Su; Xiao-Kun Zhang
Journal:  Mol Cancer Ther       Date:  2019-03-29       Impact factor: 6.261

5.  Celastrol aggravates LPS-induced inflammation and injuries of liver and kidney in mice.

Authors:  Mengqiu Wu; Weiyi Chen; Xiaowen Yu; Dan Ding; Wen Zhang; Hu Hua; Man Xu; Xia Meng; Xuejuan Zhang; Yue Zhang; Aihua Zhang; Zhanjun Jia; Songming Huang
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

6.  Transferrin-functionalised microemulsion co-delivery of β-elemene and celastrol for enhanced anti-lung cancer treatment and reduced systemic toxicity.

Authors:  Qian Zhang; Xin Tian; Xiufeng Cao
Journal:  Drug Deliv Transl Res       Date:  2019-06       Impact factor: 4.617

7.  Celastrol-loaded PEG-b-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis.

Authors:  Sean D Allen; Yu-Gang Liu; Taehyeung Kim; Sharan Bobbala; Sijia Yi; Xiaohan Zhang; Jaehyuk Choi; Evan A Scott
Journal:  Biomater Sci       Date:  2019-01-29       Impact factor: 6.843

8.  Blocking PPARγ interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression.

Authors:  Peng-Bo Yang; Pei-Pei Hou; Fu-Yuan Liu; Wen-Bin Hong; Hang-Zi Chen; Xiao-Yu Sun; Peng Li; Yi Zhang; Cui-Yu Ju; Li-Juan Luo; Sheng-Fu Wu; Jia-Xin Zhou; Zhi-Jing Wang; Jian-Ping He; Li Li; Tong-Jin Zhao; Xianming Deng; Tianwei Lin; Qiao Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-21       Impact factor: 11.205

9.  Chondro-protective effects of celastrol on osteoarthritis through autophagy activation and NF-κB signaling pathway inhibition.

Authors:  Kai Feng; Hongfang Chen; Chen Xu
Journal:  Inflamm Res       Date:  2020-02-28       Impact factor: 4.575

10.  Viral strategies for triggering and manipulating mitophagy.

Authors:  Linliang Zhang; Yali Qin; Mingzhou Chen
Journal:  Autophagy       Date:  2018-08-16       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.